These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
374 related items for PubMed ID: 11156409
21. Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities. Schmitt E, Cimoli G, Steyaert A, Bertrand R. Exp Cell Res; 1998 Apr 10; 240(1):107-21. PubMed ID: 9570926 [Abstract] [Full Text] [Related]
22. The apoptosis inhibitory domain of FE65-like protein 1 regulates both apoptotic and caspase-independent programmed cell death mediated by tumor necrosis factor. Lange A, Thon L, Mathieu S, Adam D. Biochem Biophys Res Commun; 2005 Sep 23; 335(2):575-83. PubMed ID: 16083851 [Abstract] [Full Text] [Related]
23. Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop. von Haefen C, Wieder T, Essmann F, Schulze-Osthoff K, Dörken B, Daniel PT. Oncogene; 2003 Apr 17; 22(15):2236-47. PubMed ID: 12700660 [Abstract] [Full Text] [Related]
24. Topoisomerase inhibitor camptothecin sensitizes mouse hepatocytes in vitro and in vivo to TNF-mediated apoptosis. Hentze H, Latta M, Künstle G, Dhakshinamoorthy S, Ng PY, Porter AG, Wendel A. Hepatology; 2004 May 17; 39(5):1311-20. PubMed ID: 15122760 [Abstract] [Full Text] [Related]
25. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis is dependent on activation of cysteine and serine proteases. Park IC, Park MJ, Woo SH, Lee KH, Lee SH, Rhee CH, Hong SI. Cytokine; 2001 Aug 07; 15(3):166-70. PubMed ID: 11554786 [Abstract] [Full Text] [Related]
26. Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Qin H, Srinivasula SM, Wu G, Fernandes-Alnemri T, Alnemri ES, Shi Y. Nature; 1999 Jun 10; 399(6736):549-57. PubMed ID: 10376594 [Abstract] [Full Text] [Related]
27. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific. Kissel CK, Schadendorf D, Röckmann H. Melanoma Res; 2006 Dec 10; 16(6):527-35. PubMed ID: 17119454 [Abstract] [Full Text] [Related]
28. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K, Douglas L, Delaney A, Houghton JA. Clin Cancer Res; 2004 Oct 01; 10(19):6650-60. PubMed ID: 15475455 [Abstract] [Full Text] [Related]
30. The CrmA- and TPCK-sensitive pathways that trigger oligonucleosome-sized DNA fragmentation in camptothecin-induced apoptosis: relation to caspase activation and high molecular weight DNA fragmentation. Sané AT, Schmitt E, Steyaert A, Meyer D, Bertrand R. Biochem Cell Biol; 1997 Jul 01; 75(4):359-68. PubMed ID: 9493958 [Abstract] [Full Text] [Related]
31. Overexpression of Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells. Perkins C, Kim CN, Fang G, Bhalla KN. Cancer Res; 1998 Oct 15; 58(20):4561-6. PubMed ID: 9788601 [Abstract] [Full Text] [Related]
32. Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells. Schmitt E, Steyaert A, Cimoli G, Bertrand R. Cell Death Differ; 1998 Jun 15; 5(6):506-16. PubMed ID: 10200502 [Abstract] [Full Text] [Related]
33. Detection of apoptosis induced by topoisomerase inhibitors and serum deprivation in syrian hamster embryo cells. Alexandre S, Rast C, Nguyen-Ba G, Vasseur P. Exp Cell Res; 2000 Feb 25; 255(1):30-9. PubMed ID: 10666331 [Abstract] [Full Text] [Related]
34. Nitric oxide inhibits apoptosis via AP-1-dependent CD95L transactivation. Melino G, Bernassola F, Catani MV, Rossi A, Corazzari M, Sabatini S, Vilbois F, Green DR. Cancer Res; 2000 May 01; 60(9):2377-83. PubMed ID: 10811113 [Abstract] [Full Text] [Related]
35. GDP dissociation inhibitor D4-GDI (Rho-GDI 2), but not the homologous rho-GDI 1, is cleaved by caspase-3 during drug-induced apoptosis. Essmann F, Wieder T, Otto A, Müller EC, Dörken B, Daniel PT. Biochem J; 2000 Mar 15; 346 Pt 3(Pt 3):777-83. PubMed ID: 10698706 [Abstract] [Full Text] [Related]
36. Involvement of caspase 3-activated DNase in internucleosomal DNA cleavage induced by diverse apoptotic stimuli. McIlroy D, Sakahira H, Talanian RV, Nagata S. Oncogene; 1999 Aug 05; 18(31):4401-8. PubMed ID: 10442630 [Abstract] [Full Text] [Related]
37. Identification of XAF1 as an antagonist of XIAP anti-Caspase activity. Liston P, Fong WG, Kelly NL, Toji S, Miyazaki T, Conte D, Tamai K, Craig CG, McBurney MW, Korneluk RG. Nat Cell Biol; 2001 Feb 05; 3(2):128-33. PubMed ID: 11175744 [Abstract] [Full Text] [Related]
38. RAIDD is a new 'death' adaptor molecule. Duan H, Dixit VM. Nature; 1997 Jan 02; 385(6611):86-9. PubMed ID: 8985253 [Abstract] [Full Text] [Related]
39. Chemotherapeutic drug activation of the AP24 protease in apoptosis: requirement for caspase 3-like-proteases. Wright SC, Schellenberger U, Wang H, Wang Y, Kinder DH. Biochem Biophys Res Commun; 1998 Apr 28; 245(3):797-803. PubMed ID: 9588194 [Abstract] [Full Text] [Related]
40. Identification of a new caspase homologue: caspase-14. Van de Craen M, Van Loo G, Pype S, Van Criekinge W, Van den brande I, Molemans F, Fiers W, Declercq W, Vandenabeele P. Cell Death Differ; 1998 Oct 28; 5(10):838-46. PubMed ID: 10203698 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]